"When the company reported on Oct. 30, it announced: Adjusted EPS of $1.45, exceeding analyst expectations. Total revenue declined 3% year over year due to lower sales in smokeable and oral tobacco segments Full-year 2025 adjusted EPS guidance was narrowed to $5.37 to $5.45, suggesting annual growth of 3.5% to 5%. The company expanded its share repurchase plan to $2 billion, and extended the program through December 2026."
"Among iconic American brands, Altria's Marlboro cigarettes are as recognizable as iPhones, Levi Jeans and Coca-Cola. While the company's origins can be traced back to George Weyman's tobacco shop in 1822, Altria filed its first annual report as Philip Morris in 1920 and would come to dominate U.S. tobacco throughout the 20 th century and beyond. As Philip Morris branched out to acquire General Foods and Kraft, among others, it changed its name in 2003 to Altria Group while retaining the "MO" ticker."
Altria Group shares declined sharply after subpar Q3 earnings and a recent sell-off, leaving the stock down year-to-date despite a high dividend yield. The company currently yields 7.52% and has raised distributions 60 times over 56 years. Q3 results included adjusted EPS of $1.45, revenue down 3% year-over-year from lower smokeable and oral tobacco sales, and a narrowed 2025 adjusted EPS guidance of $5.37 to $5.45. Management expanded and extended a $2 billion share-repurchase plan through December 2026. Historical strength includes Marlboro brand dominance, a name change from Philip Morris, and prior strategic investments such as a stake in Anheuser-Busch InBev.
Read at 24/7 Wall St.
Unable to calculate read time
Collection
[
|
...
]